Meeder Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Meeder Asset Management’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-413	Closed	-$7K	–	1847
2017 Q4	$7K	Buy	413 +15	+4%	+$275	﹤0.01%	1251
2017 Q3	$8K	Sell	398 -257	-39%	-$4.91K	﹤0.01%	1150
2017 Q2	$11K	Sell	655 -2,463	-79%	-$36.4K	﹤0.01%	985
2017 Q1	$40K	Buy	+3,118	New	+$37.7K	﹤0.01%	641
2015 Q2	–	Sell	-30,712	Closed	-$1.44M	–	557
2015 Q1	$1.44M	Buy	+30,712	New	+$1.22M	0.15%	184
2014 Q2	–	Sell	-48,940	Closed	-$1.29M	–	377
2014 Q1	$1.29M	Buy	+48,940	New	+$1.22M	0.21%	107
2013 Q3	–	Sell	-9,075	Closed	-$181K	–	398
2013 Q2	$181K	Buy	+9,075	New	+$161K	0.04%	274

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meeder Asset Management's IPXL Position: Q1 2018 in Review

Meeder Asset Management sold out of Impax Laboratories, Inc. (IPXL) in Q1 2018, closing a stake of 413 shares — an estimated $7K sold.

Meeder Asset Management first reported a position in IPXL in Q2 2013 and held it in 7 quarters. The position peaked at $1.44M in Q1 2015. 188 funds tracked by Wall St. Rank hold IPXL as of Q1 2018.

Meeder Asset Management reported no remaining Impax Laboratories, Inc. position as of Q1 2018 after selling out during the quarter.
Meeder Asset Management sold 413 Impax Laboratories, Inc. shares in Q1 2018, an estimated $7K.
Meeder Asset Management first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 7 quarters.
Meeder Asset Management's Impax Laboratories, Inc. position peaked at $1.44M in Q1 2015.
188 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q1 2018.

Based on Meeder Asset Management's 13F filing for Q1 2018, filed 3 May 2018.